Enzymotec Ltd. Announces Pricing of Secondary Offering
28 February 2014 - 1:00PM
Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced the
pricing of a registered secondary public offering. The size of the
offering has been increased to 4,698,857 ordinary shares at a price
of $28.00 per share. The underwriters have a 30-day option to
purchase up to an additional 704,828 ordinary shares at the public
offering price. All of the shares are being sold by the
Company's shareholders. The Company will not receive any
proceeds from the sale of these shares. The offering is
expected to close on March 5, 2014, subject to customary closing
conditions.
BofA Merrill Lynch and Jefferies LLC are serving as
joint book-running managers for the offering. Wells Fargo
Securities, LLC is serving as lead manager for the offering.
Canaccord Genuity Inc. and Wedbush Securities Inc. are serving as
co-managers for the offering.
The offering is being made solely by means of a
prospectus, copies of which may be obtained from either: BofA
Merrill Lynch, 222 Broadway, New York, NY 10038, Attention:
Prospectus Department or emailing dg.prospectus_requests@baml.com;
or Jefferies LLC, 520 Madison Ave, 12th Floor, New York, NY 10022,
877-547-6340, email: Prospectus_Department@Jefferies.com.
A registration statement relating to these
securities has been declared effective by the Securities and
Exchange Commission. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy nor shall
there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any
such state or jurisdiction.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies.
CONTACT: ICR
Katie Turner
646-277-1228
Katie.Turner@icrinc.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles